Impact evidence reports
2013
- Complex sugars could treat serious illnesses (June 2013)
- Diagnostic kits to improve pet and farm animal welfare (March 2013)
- Gene fragmentation research leads to drug discovery spinout (March 2013)
- Developing novel therapies for common skin conditions (March 2013)
- Basic bioscience supports MRSA vaccine development (March 2013)
- M-SCAN: supporting the biopharmaceutical industry (February 2013)
- A novel 3D cell culture system from spinout company Reinnervate (February 2013)
- Innovator of the Year (February 2013)
- Improving the shelf life of therapeutic proteins (January 2013)
2012
- Biopesticides regulation informed by RELU research (October 2012)
- Prolysis and Demuris: Spinouts founded on basic bacterial bioscience (October 2012)
- VSN international (October 2012)
- Conformetrix (July 2012)
- UK-India collaboration on bluetongue research (July 2012)
- Co-funding for international foot–and–mouth disease research (July 2012)
- Research influences international policies on arsenic levels in food (July 2012)
- Bioscience research supports UK equipment manufacturers (July 2012)
- David Phillips Fellows - social and policy impacts (May 2012)
- Long-term benefits from research into Streptomyces bacteria (April 2012)